Drugs / PEG/Asc
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 4 | NCT03520361 Comparator | Nov 2017 → Apr 2019 | — | KangWon National University Hospital | Unknown | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | PEG/Asc | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03520361 ↗ |
| Known as | polyethylene glycol (PEG) with ascorbic acid (Asc) | “2L polyethylene glycol (PEG) with ascorbic acid (Asc)” NCT03520361 ↗ |
| Route | Oral | “drink 1L of 2L PEG/Asc solution” NCT03520361 ↗ |